Display Settings:

Format

Send to:

Choose Destination
    Bull Cancer. 2005 Sep;92(9):763-8.

    [Proteomic profiling: the potential of Seldi-Tof for the identification of new cancer biomarkers].

    [Article in French]

    Source

    Hôpital Arnaud de Villeneuve, Inserm U540, 191, avenue du Doyen Giraud, 34295 Montpellier Cedex 5.

    Abstract

    Recent advances in proteomics offer opportunities to rapidly identify new biomarkers or pattern of markers for the early detection and diagnosis of cancer and to monitor the therapeutic efficacy and toxicity of treatments used to improve long-term survival of patients. The surfaced-enhanced laser desorption ionization/time-of-flight (Seldi-Tof) mass spectrometry is certainly one of the most promising approaches to achieve these goals. In this paper we will provide an overview of the studies that have used this new technology for the early diagnosis of human cancer.

    PMID:
    16203265
    [PubMed - indexed for MEDLINE]
    Free full text

      Supplemental Content

      Icon for John Libbey Eurotext

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk